Johnson & Johnson to pay $2.2B to settle marketing allegations
| Nov 05, 2013, 04:26:24 PM
Share
Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.